Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-01-17

Clinical Trial Update: Alpha-galactosidase Enzyme and Irritable Bowel Syndrome [NA]

View source ↗

Summary

This entry notes a clinical trial evaluating an alpha-galactosidase enzyme for irritable bowel syndrome, sponsored by Verman Oy Ab, with the trial status curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha-galactosidase enzyme (alpha-galactosidase)

Snippet

Sponsor: Verman Oy Ab | Conditions: Irritable Bowel Syndrome | NA | Status: UNKNOWN